View Filing Data

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2013	Nov. 01, 2013
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Trading Symbol	THRM
Entity Registrant Name	GENTHERM INC
Entity Central Index Key	0000903129
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		34,689,569

Consolidated Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Current Assets:
Cash & cash equivalents	$ 36,003	$ 58,152
Accounts receivable, less allowance of $2,878 and $2,474, respectively	122,330	102,261
Inventory:
Raw Materials	35,388	28,279
Work in process	2,720	2,461
Finished goods	24,698	23,016
Inventory, net	62,806	53,756
Derivative financial instruments	292	160
Deferred income tax assets	14,389	15,006
Prepaid expenses and other assets	15,222	12,809
Total current assets	251,042	242,144
Property and equipment, net	73,608	55,010
Goodwill	25,300	24,729
Other intangible assets	85,827	95,870
Deferred financing costs	1,246	1,880
Deferred income tax assets	7,772	5,361
Derivative financial instruments	2,403	4,141
Other non-current assets	10,701	10,062
Total assets	457,899	439,197
Current Liabilities:
Accounts payable	55,176	42,508
Accrued liabilities	57,696	54,157
Current maturities of long-term debt	22,164	17,218
Derivative financial instruments	2,652	3,326
Total current liabilities	137,688	117,209
Pension benefit obligation	4,961	5,009
Other liabilities	2,836	4,540
Long-term debt, less current maturities	65,270	39,734
Derivative financial instruments	9,553	13,245
Deferred income tax liabilities	21,945	21,828
Total liabilities	242,253	201,565
Series C Convertible Preferred Stock		22,469
Common Stock:
No par value; 55,000,000 shares authorized, 34,689,569 and 29,818,225 issued and outstanding at September 30, 2013 and December 31, 2012, respectively	228,985	166,309
Paid-in capital	(9,076)	24,120
Accumulated other comprehensive income (expense)	(9,308)	(11,231)
Accumulated earnings	3,854	(17,383)
Total Gentherm Incorporated shareholders’ equity	214,455	161,815
Non-controlling interest	1,191	53,348
Total shareholders’ equity	215,646	215,163
Total liabilities and shareholders’ equity	$ 457,899	$ 439,197

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Accounts receivable, allowance	$ 2,878	$ 2,474
Common Stock, par value
Common Stock, shares authorized	55,000,000	55,000,000
Common Stock, shares issued	34,689,569	29,818,225
Common Stock, shares outstanding	34,689,569	29,818,225

Consolidated Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Product revenues	$ 171,182	$ 141,058	$ 479,792	$ 406,737
Cost of sales	125,265	104,203	354,672	303,110
Gross margin	45,917	36,855	125,120	103,627
Operating expenses:
Net research and development expenses	12,718	10,257	36,962	30,566
Acquisition transaction expenses	326		1,911
Selling, general and administrative	18,319	16,560	53,483	45,972
Total operating expenses	31,363	26,817	92,356	76,538
Operating income	14,554	10,038	32,764	27,089
Interest expense	(1,062)	(898)	(2,916)	(3,082)
Revaluation of derivatives	217	(993)	1,201	(1,056)
Foreign currency gain (loss)	(1,612)	(421)	(1,514)	2,357
Income (loss) from equity investment	77	3	319	(228)
Other income	191	310	691	859
Earnings before income tax	12,365	8,039	30,545	25,939
Income tax expense	3,600	2,366	6,343	7,324
Net income	8,765	5,673	24,202	18,615
Gain attributable to non-controlling interest	(63)	(1,672)	(1,340)	(4,491)
Net income attributable to Gentherm Incorporated	8,702	4,001	22,862	14,124
Convertible preferred stock dividends	(159)	(1,516)	(1,622)	(5,521)
Net income attributable to common shareholders	$ 8,543	$ 2,485	$ 21,240	$ 8,603
Basic earnings per share	$ 0.25	$ 0.08	$ 0.64	$ 0.31
Diluted earnings per share	$ 0.24	$ 0.08	$ 0.63	$ 0.30
Weighted average number of shares – basic	34,447,098	29,618,964	33,261,115	28,177,182
Weighted average number of shares – diluted	34,886,462	30,003,347	33,584,226	28,675,643

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Net income	$ 24,202	$ 18,615
Other comprehensive income, net of tax:
Foreign currency translation adjustments	1,848	1,649
Unrealized gain (loss) on interest rate derivative securities	105	(55)
Foreign currency translation adjustments from deferred tax	(197)
Other comprehensive loss, net of tax	1,756	1,594
Comprehensive income	25,958	20,209
Less: comprehensive income attributable to the non-controlling interest	1,173	4,844
Comprehensive income attributable to Gentherm Incorporated	$ 24,785	$ 15,365

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating Activities:
Net income	$ 24,202	$ 18,615
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	23,467	22,737
Deferred tax provision	(1,138)	2,134
Stock compensation	1,861	911
Defined benefit plan expense	(159)	(303)
Provision of doubtful accounts	369	(305)
Gain on revaluation of financial derivatives	(2,859)	(1,064)
Loss (gain) on equity investment	(318)	228
Loss on sale of property, plant and equipment	48	53
Excess tax benefit from equity awards	(1,317)	(1,577)
Changes in operating assets and liabilities:
Accounts receivable	(19,606)	(16,728)
Inventory	(8,824)	(4,250)
Prepaid expenses and other assets	(2,458)	(7,264)
Accounts payable	11,250	4,622
Accrued liabilities	4,099	10,715
Net cash provided by operating activities	28,617	28,524
Investing Activities:
Purchase of non-controlling interest	(46,835)
Purchase of derivative financial instruments		(7,787)
Proceeds from the sale of property, plant and equipment	7	20
Purchase of property and equipment	(30,016)	(15,344)
Loan to equity investment		(590)
Cash invested in corporate owned life insurance	(266)	(265)
Patent costs		(1,744)
Net cash used in investing activities	(77,110)	(25,710)
Financing Activities:
Borrowing of debt	48,923	3,286
Repayments of debt	(18,966)	(19,149)
Distributions paid to non-controlling interests	(3)	(290)
Proceeds from public offering of common stock		75,487
Excess tax benefit from equity awards	1,317	1,577
Cash paid to Series C Preferred Stock Holders	(9,142)	(17,340)
Proceeds from the exercise of Common Stock options	2,901	733
Net cash provided by financing activities	25,030	46,225
Foreign currency effect	1,314	(599)
Net increase (decrease) in cash and cash equivalents	(22,149)	48,440
Cash and cash equivalents at beginning of period	58,152	23,839
Cash and cash equivalents at end of period	36,003	72,279
Supplemental disclosure of cash flow information:
Cash paid for taxes	7,174	5,678
Cash paid for interest	2,249	2,787
Supplemental disclosure of non-cash transactions:
Common stock issued to Board of Directors and employees	1,028	314
Issuance of common stock to non-controlling interest	42,517
Issuance of common stock for Series C Preferred Stock conversion	$ 15,508
W.E.T.
Financing Activities:
Proceeds from sale of W.E.T. equity to non-controlling interest		$ 1,921

Consolidated Condensed Statement of Changes In Shareholders' Equity - 9 months ended Sep. 30, 2013 - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Income (Loss)	Stockholders' Equity, Total	Noncontrolling Interest
Beginning Balance at Dec. 31, 2012	$ 215,163	$ 166,309	$ 24,120	$ (17,383)	$ (11,231)	$ 161,815	$ 53,348
Beginning Balance (in shares) at Dec. 31, 2012		29,818
Exercise of Common Stock options for cash	2,901	$ 4,023	(1,122)			2,901
Exercise of Common Stock options for cash (in shares)		437
Tax benefit from Exercises of Common Stock options	1,317		1,317			1,317
Stock issued upon conversion of preferred stock	15,108	$ 15,108				15,108
Stock issued upon conversion of preferred stock (in shares)		954
Stock option compensation	833		833			833
Common Stock issued to Board of Directors and employees	1,028	$ 1,028				1,028
Common Stock issued to Board of Directors and employees (in shares)		180
Convertible preferred stock dividends	(1,622)			(1,622)		(1,622)
Acquisition of non-controlling interest	(45,034)	$ 42,517	(34,224)			8,293	(53,327)
Acquisition of non-controlling interest (in shares)		3,300
Distribution paid to non-controlling interest	(6)			(3)		(3)	(3)
Interest rate hedge, net	105				105	105
Currency translation, net	1,848				2,015	2,015	(167)
Foreign currency translation adjustments from deferred tax	(197)				(197)	(197)
Net income	24,202			22,862		22,862	1,340
Ending Balance at Sep. 30, 2013	$ 215,646	$ 228,985	$ (9,076)	$ 3,854	$ (9,308)	$ 214,455	$ 1,191
Ending Balance (in shares) at Sep. 30, 2013		34,689

The Company and Subsequent Event

9 Months Ended

Sep. 30, 2013

The Company and Subsequent Event

Note 1 – The Company and Subsequent Event

Gentherm Incorporated is a leading supplier of thermal seat comfort and cable systems to the global automotive industry. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated. The term “historical Gentherm” used herein excludes W.E.T. Automotive Systems AG (“W.E.T.”), a subsidiary of Gentherm Incorporated. The Company performs design, development and manufacturing functions in locations aligned with our major customers’ product strategies in order to grow and expand our business around the globe. We are working to expand application of our existing technologies into new markets and products and to develop and refine new technologies to improve our existing products.

On February 22, 2013, historical Gentherm acquired an additional 442,253 shares in W.E.T., representing approximately 14% of the total outstanding shares in W.E.T., through a transaction agreement with W.E.T.’s largest minority shareholder. The Company paid 3,300,000 shares of Gentherm common stock and cash of €5,408, or $7,247, for these shares. As of September 30, 2013, we had acquired an additional 309,537 shares in W.E.T., raising our total ownership interest in W.E.T. above 99%. These additional shares were purchased at a price of €85 per share for a total of €26,311, or $35,256. Gentherm borrowed an additional $40,441 from the US Bank of America credit facility in connection with the purchase of these shares. See Note 6 below for additional information about the US Bank of America credit facility.

On February 22, 2013, the Company registered a Domination and Profit and Loss Transfer Agreement (“DPLTA”) in Germany with respect to W.E.T. The DPLTA essentially allows historical Gentherm and W.E.T. to be managed as one operational entity.

Subsequent Event

On October 31, 2013, the Company announced that it had registered a squeeze-out transaction in Germany and now owns 100 percent of the outstanding shares of W.E.T. As a result of the squeeze-out, the remaining shares of W.E.T., representing less than one percent of W.E.T.’s outstanding shares, were transferred to Gentherm and the applicable minority shareholders are entitled to receive €90.05 per share held at the time of registration.

Basis of Presentation and New Accounting Pronouncements

9 Months Ended

Sep. 30, 2013

Basis of Presentation and New Accounting Pronouncements

Note 2 – Basis of Presentation and New Accounting Pronouncements

The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation have been included. The balance sheet as of December 31, 2012 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Operating results for the nine month period ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. It is suggested that these consolidated condensed financial statements be read in conjunction with the financial statements and the notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K.

Hedge Accounting

In July 2013, the Financial Accounting Standards Board (FASB) issued ASU 2013-10 which permits the use of the Overnight Index Swap Rate (OIS), also referred to as the Fed Fund Effective Swap Rate as a U.S. GAAP benchmark interest rate for hedge accounting purposes under Topic 815. Currently, only the interest rates on direct Treasury obligations of the U.S. government (UST) and the London Interbank Offered Rate (LIBOR) swap rate are considered benchmark interest rates in the United States. This update also removes the restriction on using different benchmark rates for similar hedges. Including the Fed Funds Effective Swap Rate as an acceptable U.S. benchmark interest rate in addition to UST and LIBOR will provide risk managers with a more comprehensive spectrum of interest rate resets to utilize as the designated interest risk component under the hedge accounting guidance in Topic 815. The amendments of this ASU are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013.

Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued

We do not anticipate that the adoption of this guidance will have a material effect on our consolidated balance sheet or statement of operations.

Unrecognized Tax Benefits

ASU 2013-11, issued in July 2013, requires that an unrecognized tax benefit be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. When a net operating loss, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional taxes that would result from the disallowance of a tax position, or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purposes, the unrecognized tax benefit should be presented in the financial statements as a liability. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date.

ASU 2013-11 is effective for fiscal years and interim periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. As Gentherm already nets together an unrecognized tax benefit associated with a deferred tax asset from tax credit carryforwards, we do not anticipate an impact to our consolidated balance sheet resulting from the adoption of this guidance.

Tax Regulation

The Company is evaluating the impact of the regulations concerning amounts paid to acquire, produce, or improve tangible property and recovery of basis upon disposition. Because the revenue procedures governing the tangible property regulations will not be issued until the fourth quarter, the Company is still determining whether or not any changes in accounting method will be required and if they will result in a material impact to its financial statements. At this time, the Company does not anticipate there being a material impact.

Earnings Per Share

9 Months Ended

Sep. 30, 2013

Earnings Per Share

Note 3 – Earnings per Share

Basic earnings per common share are computed by dividing net income by the weighted average number of shares of stock outstanding. The Company’s diluted earnings per common share give effect to all potential shares of Common Stock outstanding during a period that are not anti-dilutive. In computing the diluted earnings per share, the treasury stock and if converted methods are used in determining the number of shares assumed to be purchased from the conversion of Common Stock equivalents.

The following summarizes the amounts included in the dilutive shares as disclosed on the face of the consolidated condensed statements of operations:

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Weighted average number of shares for calculation of basic EPS – Common Stock		34,447,098	29,618,964		33,261,115	28,177,182
Impact of stock options outstanding under the 1997, 2006 and 2011 Stock Option Plans		439,364	384,383		323,111	498,461
Weighted average number of shares for calculation of diluted EPS		34,886,462	30,003,347		33,584,226	28,675,643

The accompanying table represents Common Stock issuable upon the exercise of certain stock options, the Series C Convertible Preferred Stock and potential dividends paid in common stock that have been excluded from the diluted shares calculation because the effect of their inclusion would be anti-dilutive.

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Stock options outstanding under the 2006, 2011 and 2013 Stock Option Plans		500,000	584,586		508,000	584,586
Series C Convertible Preferred Stock		—	2,092,291		—	2,092,291
		500,000	2,676,877		508,000	2,676,877

Segment Reporting

9 Months Ended

Sep. 30, 2013

Segment Reporting

Note 4 – Segment Reporting

Segment information is used by management for making operating decisions and assessing the performance of the Company. Management evaluates the performance of its segments based primarily on operating income.

The Company’s reportable segments are as follows:

 Climate Control Seats (CCS) – variable temperature seat climate control system designed to improve the temperature comfort of automobile passengers. This segment also includes the heated and cooled cup holder and heated and cooled mattress divisions. This segment represents historical Gentherm business only. It does not include seat climate control products of historical W.E.T.

 Advanced Technology – a division engaged in research and development efforts to improve the efficiency of thermoelectric devices and to develop, market and distribute products based on this new technology. It includes U.S. Department of Energy sponsored research projects, such as the development of a commercially viable thermoelectric generator.

 W.E.T. Automotive AG (W.E.T.) – W.E.T. is being evaluated currently as an individual segment until such time as Gentherm is able to fully evaluate and implement its future integration plans and strategy.

The tables below present segment information about the reported product revenues and operating income of the Company for the three month period ended September 30, 2013 and 2012. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level at this time. Goodwill as of September 30, 2013 and 2012 pertained entirely to our W.E.T. segment.

Three Months Ended September 30,	CCS
2013:
Product revenues	$	37,697	$	—		$	133,485	$	—		$	171,182
Depreciation and amortization		437		117			6,870		313			7,737
Operating income (loss)		11,152		(1,544	)		11,297		(6,351	)		14,554
2012:
Product revenues	$	33,966	$	—		$	107,092	$	—		$	141,058
Depreciation and amortization		329		82			6,692		342			7,445
Operating income (loss)		9,328		(1,631	)		8,249		(5,908	)		10,038

The Advanced Technology operating loss for the three months ended September 30, 2013 and 2012 is net of $375 and $656, respectively, of reimbursed research and development costs. Reconciling items include historical Gentherm’s corporate selling, general and administrative costs and acquisition transaction costs.

Nine Months Ended September 30,	CCS
2013:
Product revenues	$	103,460	$	—		$	376,332	$	—		$	479,792
Depreciation and amortization		1,115		344			21,143		865			23,467
Operating income (loss)		28,953		(5,174	)		28,407		(19,422	)		32,764
2012:
Product revenues	$	96,117	$	—		$	310,620	$	—		$	406,737
Depreciation and amortization		787		388			20,697		865			22,737
Operating income (loss)		25,037		(5,260	)		22,274		(14,962	)		27,089

The Advanced Technology operating loss for the nine months ended September 30, 2013 and 2012 is net of $1,597 and $1,763, respectively, of reimbursed research and development costs. Reconciling items include historical Gentherm’s corporate selling, general and administrative costs and acquisition transaction costs.

Note 4 – Segment Reporting – Continued

Total product revenues information by geographic area:

	Three Months Ended September 30,
	2013					2012
United States	$	76,543	45	%	$		60,012	42	%
Germany		20,847	12	%			17,773	13	%
China		18,285	11	%			15,694	11	%
South Korea		13,546	8	%			10,716	8	%
Japan		10,281	6	%			10,294	7	%
United Kingdom		5,180	3	%			3,407	2	%
Mexico		4,230	2	%			3,581	3	%
Czech Republic		4,114	2	%			4,375	3	%
Canada		3,432	2	%			2,782	2	%
Other		14,724	9	%			12,424	9	%
Total product revenues	$	171,182	100	%	$		141,058	100	%

	Nine Months Ended September 30,
	2013					2012
United States	$	211,462	44	%	$		173,233	43	%
Germany		61,332	13	%			49,405	12	%
China		47,972	10	%			43,510	11	%
South Korea		39,069	8	%			31,213	8	%
Japan		28,591	6	%			24,014	6	%
United Kingdom		13,319	3	%			12,959	3	%
Czech Republic		11,893	3	%			12,102	3	%
Mexico		11,696	2	%			11,467	3	%
Canada		10,533	2	%			9,527	2	%
Other		43,925	9	%			39,307	10	%
Total product revenues	$	479,792	100	%	$		406,737	100	%

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

Series C Convertible Preferred Stock

9 Months Ended

Sep. 30, 2013

Series C Convertible Preferred Stock

Note 5 – Series C Convertible Preferred Stock

In March 2011, the Company issued 7,000 shares of our Series C Convertible Preferred Stock (each a “Preferred Share” and, collectively, the “Preferred Shares”) having an initial stated value of $10,000 per Preferred Share, subject to adjustment. We received approximately $64,013 in net proceeds from the sale, after deducting placement agent fees and other offering expenses which totaled $5,987. We used the net proceeds from this offering to fund, in part, the W.E.T. acquisition.

Holders of the Series C Convertible Preferred Stock were entitled to receive, out of funds legally available therefore, dividends payable in cash (if permitted under the US Bank of America credit facility), our Common Stock (if certain equity conditions are satisfied or waived as of the applicable date), or any combination thereof, at the election of the Company, at the rate of 8% per annum of the stated value, payable quarterly in arrears on September 1, December 1, March 1 and June 1 of each year, commencing September 1, 2011. Dividends on our Series C Convertible Preferred Stock are cumulative from the date of initial issuance.

The Series C Convertible Preferred Stock was to be redeemed in nine equal quarterly installments that began on September 1, 2011 and ended September 1, 2013 (each, an “Amortization Date”) by paying cash, issuing shares of our Common Stock or any combination thereof for $10,000 per Preferred Share plus accumulated and unpaid dividends.

Note 5 – Series C Convertible Preferred Stock – Continued

Holders of the Series C Convertible Preferred Stock could have converted their shares at any time into shares of common stock at a conversion price of $15.83, including the conversion of accrued but unpaid dividends per Preferred Share then remaining into shares of common stock, and in addition would be entitled to a make-whole amount that would apply in a conversion (reflecting dividends that would have been payable through maturity if the Series C Convertible Preferred Stock had remained outstanding); provided, however, that under certain conditions where our US Bank of America credit facility prohibits payment of the make-whole amount, we would only be obligated to pay such make-whole amount at the time such amount, or portion thereof, would have been due to be paid as a dividend as if the Series C Convertible Preferred Stock at issue had not been converted.

In March 2013, holders of the Series C Convertible Preferred Stock elected to convert 165 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 105,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

In May 2013, holders of the Series C Convertible Preferred Stock elected to convert 650 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 418,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

During the months of July and August, 2013, holders of the Series C Convertible Preferred Stock elected to convert all unredeemed remaining shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 432,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

Total Series C Convertible Preferred Stock installments paid in cash during the nine months period ended September 30, 2013 is as follows:

	Installment Payments ($)
Dividend	$	696
Principal		8,446
Total	$	9,142

Debt

9 Months Ended

Sep. 30, 2013

Debt

Note 6 – Debt

Gentherm, Inc. and our subsidiary, Gentherm Europe, have entered into a credit agreement with a syndicate of banks led by Bank of America (the “US Bank of America credit facility”). W.E.T., a subsidiary of Gentherm Europe, has also entered into a credit facility with the same syndicate of banks (the “W.E.T. Bank of America credit facility”).

The US Bank of America credit facility provided two term notes (referred to as the “US Term Note and Europe Term Note”) and a revolving line of credit note (“US Revolving Note”). The W.E.T. Bank of America credit facility provided W.E.T. with a term note (“W.E.T. Term Note”) and a revolving line of credit note (“W.E.T. Revolving Note”).

The US Term Note and Europe Term Note are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 10% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Term Note is subject to quarterly principal payments totaling 20% annually. Principal outstanding under the two credit facilities will be due and payable in full on March 30, 2016. Interest is payable at least quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EURIBOR) rate (“Eurocurrency Rate Loans”) (0.17% – 0.45% at September 30, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. The base rate is equal to the highest of the Federal Funds Rate (0.06% at September 30, 2013) plus 0.5%, Bank of America’s prime rate (3.25% at September 30, 2013), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period was 2.25% for Eurocurrency Rate Loans and 1.25% for Base Rate Loans. The Company must maintain a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio, as defined by the Bank of America credit agreement. The loans are secured by all of the Company’s assets.

In February 2013, the Company made a $40,441 draw on the existing Europe Term Note portion of the US Bank of America credit facility to finance the purchase of shares of WET held by non-controlling interests. The Europe Term Note has expired and additional draws are not available to Gentherm.

Note 6 – Debt – Continued

In September 2012, we borrowed CN¥20,000, or $3,159, from Bank of China to fund a plant expansion project in China. The Bank of China loan was paid in full on September 10, 2013 with interest calculated at a fixed rate of 6.9%.

In May 2013, the Company made an initial draw of €2,000, or $2,601, on a loan from the German Investment Corporation, a subsidiary of KfW banking group, a German government-owned development bank (“DEG Loan”), to fund the China plant expansion project. An additional draw of €2,000, or $2,701, was made in September and the entire loan balance was rolled into a fixed interest rate loan with an interest rate of 3% plus a Euro Swap Rate of 1.25%. The Bank of China short term financing used to complete the project was repaid from funds available under the DEG Loan. The DEG Loan is subject to semi-annual principal payments beginning March, 2015 and ending September, 2019. Under the terms of the loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio based on the financial statements of W.E.T. Automotive Systems (China) Limited, as defined by the DEG Loan agreement.

The Company’s capital lease agreement for an enterprise resource planning system ended in May. A new lease agreement for an enterprise resource planning system commenced June, 2013 and will end May, 2015. Under the terms of the lease, the Company must maintain certain financial covenants. Ownership of the system will be transferred to the Company at the end of the agreement.

No amounts were outstanding under either the US Revolving Note or the W.E.T. Revolving Note as of September 30, 2013 and $29,550 and €20,000 were available under each note, respectively. Gentherm has an outstanding Letter of Credit of $450 as of September 30, 2013.

The following table summarizes the Company’s debt at September 30, 2013 and at December 31, 2012.

	September 30, 2013						December 31, 2012
	Interest Rate			Principal Balance			Principal Balance
US Term Note		2.50	%	$	25,813		$	29,312
Europe Term Note		2.50	%		40,507			4,476
W.E.T. Term Note		2.00	%		12,897			18,852
DEG Loan		4.25	%		5,403			—
Capital Leases		4.20	%		2,814			1,140
Bank of China					—			3,172
Total debt					87,434			56,952
Current portion					(22,164	)		(17,218	)
Long-term debt, less current maturities				$	65,270		$	39,734

As of September 30, 2013, we were in compliance with all terms as outlined in the credit agreement for each of the US Bank of America credit facility, the W.E.T. Bank of America credit facility, the DEG loan and the capital lease agreement.

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2013

Derivative Financial Instruments

Note 7 – Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities such as copper. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Canadian Dollar, Japanese Yen, Hungarian Forint, Korean Won and Mexican Peso. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. We record the ineffective portion of hedging instruments, if any, to other income (expense) in the consolidated condensed statements of operations.

Note 7 – Derivative Financial Instruments – Continued

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000, or $13,508 as of September 30, 2013, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then nine month Euro Interbank Offered Rate (“EURIBOR”), 0.45% at September 30, 2013, plus 1.40% and pays interest equal to the nine month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.23 at September 30, 2013, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100. In 2012, W.E.T. entered into offsetting derivative contracts designed to cancel out the payment due under the CRS through the end of the CRS agreement, in 2018.

In September 2011, W.E.T. brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of W.E.T., asserting that UniCredit violated its duty to properly advise W.E.T. with respect to the initial negative market value for the CRS and UniCredit’s inherent conflict of interest in recommending that W.E.T. invest in CRS. The Munich District Court ruled that UniCredit must (1) pay €144 to W.E.T. and (2) bear the costs of all future obligations under the CRS, which were €8,906 or $12,030 as of September 30, 2013, plus additional accrued liabilities for past due payments under the CRS of approximately €4,930, or $6,659 as of September 30, 2013. UniCredit has appealed the decision. As a result, the Company cannot be certain that any portion of the decision by the Munich District Court will be realized by W.E.T. See the derivatives table below for information about our future obligations under the CRS as of September 30, 2013.

In July 2011, the Company entered into a series of interest rate swap contracts designated as cash flow hedges and an interest rate cap agreement in order to hedge the exposure to variable market interest rates on the Company’s senior debt. Gains and losses reported in accumulated other comprehensive income will be reclassified to earnings once the Company’s senior debt is repaid.

The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated balance sheet as of September 30, 2013 is as follows:

			Asset Derivatives			Liability Derivatives
	Hedge Designation	Fair Value Hierarchy	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
CRS	Not a hedge	Level 2				Current liabilities	$	(2,476	)
						Non current liabilities		(9,553	)
Total CRS							$	(12,029	)	$	(12,029	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	3	Current liabilities	$	(57	)	$	(54	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	289					$	289
			Non current assets		2,403					$	2,403
Total foreign currency derivatives				$	2,695		$	(57	)	$	2,638
Interest rate swap derivatives	Cash flow hedge	Level 2				Current liabilities	$	(119	)	$	(119	)

Note 7 – Derivative Financial Instruments – Continued

Information relating to the effect of derivative instruments on our consolidated income statements is as follows:

	Location	Three Months Ended September 30, 2013			Nine Months Ended September 30, 2013
Foreign currency derivatives	Revaluation of derivatives	$	581		$	(694	)
	Foreign currency gain (loss)		(426	)		(844	)
Total foreign currency derivatives		$	155		$	(1,538	)
CRS	Revaluation of derivatives	$	(364	)	$	1,895
Commodity derivatives	Revaluation of derivatives	$	—		$	—
Interest Rate Swap	Interest Expense	$	8		$	8
	Other Comprehensive Income	$	30		$	105

	Location	Three Months Ended September 30, 2012			Nine Months Ended September 30, 2012
Foreign currency derivatives	Revaluation of derivatives	$	(2,036	)	$	(2,514	)
	Foreign currency gain (loss)		1,051			1,722
Total foreign currency derivatives		$	(985	)	$	(792	)
CRS	Revaluation of derivatives	$	1,045		$	1,315
Commodity derivatives	Revaluation of derivatives	$	(2	)	$	143
Interest Rate Swap	Interest Expense	$	(12	)	$	(54	)
	Other Comprehensive Income	$	(25	)	$	(55	)

We did not incur any hedge ineffectiveness during the nine months ended September 30, 2013 and 2012.

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41678-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Fair Value Measurement

9 Months Ended

Sep. 30, 2013

Fair Value Measurement

Note 8 – Fair Value Measurement

The Company bases fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

The Company’s derivative instruments and hedging activities and pension assets qualify as financial assets and liabilities whose fair value is measured on a recurring basis each reporting period. Fair value measurement disclosures for our derivative instruments and hedging activities are located within Note 7. The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments and accounts receivable approximate their fair values due to their short-term nature. The carrying value of the Company’s long-term debt approximates its fair value because interest charged on the loan balance is variable. There were no significant changes to interest rates during the period.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of September 30, 2013 and 2012, the Company did not realize any changes to the fair value of these assets due to events that negatively impacted their recoverability.

Basis of Presentation and New Accounting Pronouncements (Policies)

9 Months Ended

Sep. 30, 2013

New Accounting Pronouncements

Hedge Accounting

Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued

We do not anticipate that the adoption of this guidance will have a material effect on our consolidated balance sheet or statement of operations.

Unrecognized Tax Benefits

Tax Regulation

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2013

Dilutive Shares of Consolidated Condensed Statements of Operations

The following summarizes the amounts included in the dilutive shares as disclosed on the face of the consolidated condensed statements of operations:

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Weighted average number of shares for calculation of basic EPS – Common Stock		34,447,098	29,618,964		33,261,115	28,177,182
Impact of stock options outstanding under the 1997, 2006 and 2011 Stock Option Plans		439,364	384,383		323,111	498,461
Weighted average number of shares for calculation of diluted EPS		34,886,462	30,003,347		33,584,226	28,675,643

Common Stock Issuable upon Exercise of Certain Stock Options

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Stock options outstanding under the 2006, 2011 and 2013 Stock Option Plans		500,000	584,586		508,000	584,586
Series C Convertible Preferred Stock		—	2,092,291		—	2,092,291
		500,000	2,676,877		508,000	2,676,877

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2013

Segment Information about Reported Product Revenues and Operating Income

Three Months Ended September 30,	CCS
2013:
Product revenues	$	37,697	$	—		$	133,485	$	—		$	171,182
Depreciation and amortization		437		117			6,870		313			7,737
Operating income (loss)		11,152		(1,544	)		11,297		(6,351	)		14,554
2012:
Product revenues	$	33,966	$	—		$	107,092	$	—		$	141,058
Depreciation and amortization		329		82			6,692		342			7,445
Operating income (loss)		9,328		(1,631	)		8,249		(5,908	)		10,038

Nine Months Ended September 30,	CCS
2013:
Product revenues	$	103,460	$	—		$	376,332	$	—		$	479,792
Depreciation and amortization		1,115		344			21,143		865			23,467
Operating income (loss)		28,953		(5,174	)		28,407		(19,422	)		32,764
2012:
Product revenues	$	96,117	$	—		$	310,620	$	—		$	406,737
Depreciation and amortization		787		388			20,697		865			22,737
Operating income (loss)		25,037		(5,260	)		22,274		(14,962	)		27,089

Product Revenues Information by Geographic Area

Total product revenues information by geographic area:

	Three Months Ended September 30,
	2013					2012
United States	$	76,543	45	%	$		60,012	42	%
Germany		20,847	12	%			17,773	13	%
China		18,285	11	%			15,694	11	%
South Korea		13,546	8	%			10,716	8	%
Japan		10,281	6	%			10,294	7	%
United Kingdom		5,180	3	%			3,407	2	%
Mexico		4,230	2	%			3,581	3	%
Czech Republic		4,114	2	%			4,375	3	%
Canada		3,432	2	%			2,782	2	%
Other		14,724	9	%			12,424	9	%
Total product revenues	$	171,182	100	%	$		141,058	100	%

	Nine Months Ended September 30,
	2013					2012
United States	$	211,462	44	%	$		173,233	43	%
Germany		61,332	13	%			49,405	12	%
China		47,972	10	%			43,510	11	%
South Korea		39,069	8	%			31,213	8	%
Japan		28,591	6	%			24,014	6	%
United Kingdom		13,319	3	%			12,959	3	%
Czech Republic		11,893	3	%			12,102	3	%
Mexico		11,696	2	%			11,467	3	%
Canada		10,533	2	%			9,527	2	%
Other		43,925	9	%			39,307	10	%
Total product revenues	$	479,792	100	%	$		406,737	100	%

Series C Convertible Preferred Stock (Tables)

9 Months Ended

Sep. 30, 2013

Series C Convertible Preferred Stock Installments

Total Series C Convertible Preferred Stock installments paid in cash during the nine months period ended September 30, 2013 is as follows:

	Installment Payments ($)
Dividend	$	696
Principal		8,446
Total	$	9,142

Debt (Tables)

9 Months Ended

Sep. 30, 2013

Summary of Company's debt

The following table summarizes the Company’s debt at September 30, 2013 and at December 31, 2012.

	September 30, 2013						December 31, 2012
	Interest Rate			Principal Balance			Principal Balance
US Term Note		2.50	%	$	25,813		$	29,312
Europe Term Note		2.50	%		40,507			4,476
W.E.T. Term Note		2.00	%		12,897			18,852
DEG Loan		4.25	%		5,403			—
Capital Leases		4.20	%		2,814			1,140
Bank of China					—			3,172
Total debt					87,434			56,952
Current portion					(22,164	)		(17,218	)
Long-term debt, less current maturities				$	65,270		$	39,734

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Information related to the recurring fair value measurement of derivative instruments in our consolidated balance sheet as of September 30, 2013 is as follows:

			Asset Derivatives			Liability Derivatives
	Hedge Designation	Fair Value Hierarchy	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
CRS	Not a hedge	Level 2				Current liabilities	$	(2,476	)
						Non current liabilities		(9,553	)
Total CRS							$	(12,029	)	$	(12,029	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	3	Current liabilities	$	(57	)	$	(54	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	289					$	289
			Non current assets		2,403					$	2,403
Total foreign currency derivatives				$	2,695		$	(57	)	$	2,638
Interest rate swap derivatives	Cash flow hedge	Level 2				Current liabilities	$	(119	)	$	(119	)

Information Relate to Effect of Derivative Instruments on Our Consolidated Income Statements

Note 7 – Derivative Financial Instruments – Continued

Information relating to the effect of derivative instruments on our consolidated income statements is as follows:

	Location	Three Months Ended September 30, 2013			Nine Months Ended September 30, 2013
Foreign currency derivatives	Revaluation of derivatives	$	581		$	(694	)
	Foreign currency gain (loss)		(426	)		(844	)
Total foreign currency derivatives		$	155		$	(1,538	)
CRS	Revaluation of derivatives	$	(364	)	$	1,895
Commodity derivatives	Revaluation of derivatives	$	—		$	—
Interest Rate Swap	Interest Expense	$	8		$	8
	Other Comprehensive Income	$	30		$	105

	Location	Three Months Ended September 30, 2012			Nine Months Ended September 30, 2012
Foreign currency derivatives	Revaluation of derivatives	$	(2,036	)	$	(2,514	)
	Foreign currency gain (loss)		1,051			1,722
Total foreign currency derivatives		$	(985	)	$	(792	)
CRS	Revaluation of derivatives	$	1,045		$	1,315
Commodity derivatives	Revaluation of derivatives	$	(2	)	$	143
Interest Rate Swap	Interest Expense	$	(12	)	$	(54	)
	Other Comprehensive Income	$	(25	)	$	(55	)

The Company and Subsequent Event - Additional Information (Detail) € / shares in Units, € in Thousands, $ in Thousands	1 Months Ended		9 Months Ended
	Feb. 22, 2013 USD ($) shares	Feb. 22, 2013 EUR (€) shares	Sep. 30, 2013 USD ($) shares	Sep. 30, 2013 EUR (€)	Oct. 31, 2013 € / shares	Sep. 30, 2013 € / shares
Nature Of Company [Line Items]
Business Acquisition, shares issued for acquisition \| shares	3,300,000	3,300,000
Business Acquisition, cash paid	$ 7,247	€ 5,408
W.E.T. Bank of America credit facility
Nature Of Company [Line Items]
Business Acquisition, cash paid			$ 26,311	€ 35,256
Business Acquisition, purchase price per share \| € / shares						€ 85
Business Acquisition cost of acquisition, financed by borrowings \| $			$ 40,441
W.E.T. Bank of America credit facility \| Subsequent Event
Nature Of Company [Line Items]
Business Acquisition, percentage of shares acquired					100.00%
Business Acquisition, purchase price per share \| € / shares					€ 90.05
W.E.T. Bank of America credit facility \| Minimum
Nature Of Company [Line Items]
Business Acquisition, percentage of shares acquired			99.00%
Subsidiaries \| Historical Gentherm
Nature Of Company [Line Items]
Business Acquisition, shares acquired \| shares	442,253	442,253	309,537
Business Acquisition, percentage of shares acquired	14.00%	14.00%

Earnings per Share (Detail) - shares	3 Months Ended		9 Months Ended
Earnings per Share (Detail) - shares	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Weighted average number of shares for calculation of basic EPS – Common Stock	34,447,098	29,618,964	33,261,115	28,177,182
Impact of stock options outstanding under the 1997, 2006 and 2011 Stock Option Plans	439,364	384,383	323,111	498,461
Weighted average number of shares – diluted	34,886,462	30,003,347	33,584,226	28,675,643
Common stock that have been excluded from the diluted shares calculation	500,000	2,676,877	508,000	2,676,877
Stock options outstanding under the 2006, 2011 and 2013 Stock Option Plans
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Common stock that have been excluded from the diluted shares calculation	500,000	584,586	508,000	584,586
Series C Convertible Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Common stock that have been excluded from the diluted shares calculation		2,092,291		2,092,291

Segment Information about Reported Product Revenues and Operating Income (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Product revenues	$ 171,182	$ 141,058	$ 479,792	$ 406,737
Depreciation and amortization	7,737	7,445	23,467	22,737
Operating income (loss)	14,554	10,038	32,764	27,089
CCS
Segment Reporting Information [Line Items]
Product revenues	37,697	33,966	103,460	96,117
Depreciation and amortization	437	329	1,115	787
Operating income (loss)	11,152	9,328	28,953	25,037
Advanced Technology
Segment Reporting Information [Line Items]
Depreciation and amortization	117	82	344	388
Operating income (loss)	(1,544)	(1,631)	(5,174)	(5,260)
W.E.T.
Segment Reporting Information [Line Items]
Product revenues	133,485	107,092	376,332	310,620
Depreciation and amortization	6,870	6,692	21,143	20,697
Operating income (loss)	11,297	8,249	28,407	22,274
Reconciling Items
Segment Reporting Information [Line Items]
Depreciation and amortization	313	342	865	865
Operating income (loss)	$ (6,351)	$ (5,908)	$ (19,422)	$ (14,962)

Segment Reporting (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Segment Reporting (Detail) - USD ($) $ in Thousands	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Total product revenues	$ 171,182	$ 141,058	$ 479,792	$ 406,737
Total product revenues in percentage	100.00%	100.00%	100.00%	100.00%
United States
Segment Reporting Information [Line Items]
Total product revenues	$ 76,543	$ 60,012	$ 211,462	$ 173,233
Total product revenues in percentage	45.00%	42.00%	44.00%	43.00%
Germany
Segment Reporting Information [Line Items]
Total product revenues	$ 20,847	$ 17,773	$ 61,332	$ 49,405
Total product revenues in percentage	12.00%	13.00%	13.00%	12.00%
China
Segment Reporting Information [Line Items]
Total product revenues	$ 18,285	$ 15,694	$ 47,972	$ 43,510
Total product revenues in percentage	11.00%	11.00%	10.00%	11.00%
South Korea
Segment Reporting Information [Line Items]
Total product revenues	$ 13,546	$ 10,716	$ 39,069	$ 31,213
Total product revenues in percentage	8.00%	8.00%	8.00%	8.00%
Japan
Segment Reporting Information [Line Items]
Total product revenues	$ 10,281	$ 10,294	$ 28,591	$ 24,014
Total product revenues in percentage	6.00%	7.00%	6.00%	6.00%
United Kingdom
Segment Reporting Information [Line Items]
Total product revenues	$ 5,180	$ 3,407	$ 13,319	$ 12,959
Total product revenues in percentage	3.00%	2.00%	3.00%	3.00%
Mexico
Segment Reporting Information [Line Items]
Total product revenues	$ 4,230	$ 3,581	$ 11,696	$ 11,467
Total product revenues in percentage	2.00%	3.00%	2.00%	3.00%
Czech Republic
Segment Reporting Information [Line Items]
Total product revenues	$ 4,114	$ 4,375	$ 11,893	$ 12,102
Total product revenues in percentage	2.00%	3.00%	3.00%	3.00%
Canada
Segment Reporting Information [Line Items]
Total product revenues	$ 3,432	$ 2,782	$ 10,533	$ 9,527
Total product revenues in percentage	2.00%	2.00%	2.00%	2.00%
Other
Segment Reporting Information [Line Items]
Total product revenues	$ 14,724	$ 12,424	$ 43,925	$ 39,307
Total product revenues in percentage	9.00%	9.00%	9.00%	10.00%

Segment Reporting - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Advanced Technology
Segment Reporting Information [Line Items]
Reimbursed research and development costs	$ 375	$ 656	$ 1,597	$ 1,763

Series C Convertible Preferred Stock - Additional Information (Detail) - Series C Convertible Preferred Stock	1 Months Ended		2 Months Ended	3 Months Ended	9 Months Ended
	May 31, 2013 $ / shares shares	Mar. 31, 2011 USD ($) $ / shares shares	Aug. 31, 2013 $ / shares shares	Mar. 31, 2013 $ / shares shares	Sep. 30, 2013 USD ($) Installment
Preferred Stock [Line Items]
Preferred shares issued \| shares		7,000
Initial stated value per preferred share \| $ / shares		$ 10,000
Net proceeds from sale of shares \| $		$ 64,013,000
Agent fees and offering costs \| $		$ 5,987,000
Percentage of dividend payable					8.00%
Number of equal quarterly installments \| Installment					9
Installments start date					Sep. 01, 2011
Installments end date					Sep. 01, 2013
Preferred share plus accumulated and unpaid dividends \| $					$ 10,000
Conversion price of convertible preference stock \| $ / shares	$ 15.83		$ 15.83	$ 15.83
Conversion share of convertible preference stock \| shares	650			165
Issuance of common stock related to conversion of preferred stock \| shares	418,000		432,000	105,000

Series C Convertible Preferred Stock Installments (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2013 USD ($)
Class Of Stock [Line Items]
Dividend, installment payments	$ 696
Principal, installment payments	8,446
Total, installment payments	$ 9,142

Debt - Additional Information (Detail) € in Thousands, ¥ in Thousands, $ in Thousands	1 Months Ended	9 Months Ended
	Sep. 30, 2013 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2013 EUR (€)	Sep. 30, 2013 EUR (€)	Feb. 28, 2013 USD ($)	Sep. 30, 2012 USD ($)	Sep. 30, 2012 CNY (¥)
Debt Disclosure [Line Items]
Principal amortization of credit facility percentage year one		10.00%	10.00%
Principal amortization of credit facility percentage year two		12.50%	12.50%
Principal amortization of credit facility percentage year three		15.00%	15.00%
Principal amortization of credit facility percentage year four		17.50%	17.50%
Principal amortization of credit facility percentage year five		10.00%	10.00%
Credit facility due date		Mar. 30, 2016	Mar. 30, 2016
Debt instrument, description		The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EURIBOR) rate (“Eurocurrency Rate Loans”) (0.17% – 0.45% at September 30, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements.	The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EURIBOR) rate (“Eurocurrency Rate Loans”) (0.17% – 0.45% at September 30, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements.
Line of credit facility	$ 29,550	$ 29,550		€ 20,000
Outstanding letter of credit	450	$ 450
Europe Term Note
Debt Disclosure [Line Items]
Amount of draw on europe term note					$ 40,441
W.E.T. Bank of America credit facility
Debt Disclosure [Line Items]
Quarterly principal payments		20.00%	20.00%
W.E.T. Bank of America credit facility \| Minimum
Debt Disclosure [Line Items]
Interest rate		1.00%	1.00%
Eurocurrency Rate Loans
Debt Disclosure [Line Items]
Interest rate		2.25%	2.25%
Eurocurrency Rate Loans \| Minimum
Debt Disclosure [Line Items]
Interest rate		0.20%	0.20%
Eurocurrency Rate Loans \| Maximum
Debt Disclosure [Line Items]
Interest rate		0.40%	0.40%
Federal Funds Rate \| Minimum
Debt Disclosure [Line Items]
Interest rate		0.06%	0.06%
Federal Funds Rate \| Maximum
Debt Disclosure [Line Items]
Interest rate		0.50%	0.50%
US Bank of America credit facility \| Maximum
Debt Disclosure [Line Items]
Interest rate		3.25%	3.25%
Base Rate Loans
Debt Disclosure [Line Items]
Interest rate		1.25%	1.25%
Bank of China
Debt Disclosure [Line Items]
Debt instrument face amount						$ 3,159	¥ 20,000
Fixed interest rate						6.90%	6.90%
German Investment Corporation
Debt Disclosure [Line Items]
Interest rate		4.25%	4.25%
Initial amount drawn from German Investment Corporation		$ 2,601	€ 2,000
Line of credit facility	$ 2,701	$ 2,701		€ 2,000
German Investment Corporation \| Euro Swap Rate
Debt Disclosure [Line Items]
Interest rate	3.00%
Spread variable interest rate	1.25%

Summary of Company's debt (Detail) - USD ($) $ in Thousands	9 Months Ended
Summary of Company's debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Total debt	$ 87,434	$ 56,952
Current portion	(22,164)	(17,218)
Long-term debt, less current maturities	$ 65,270	39,734
US Term Note
Debt Instrument [Line Items]
Interest Rate	2.50%
Total debt	$ 25,813	29,312
Europe Term Note
Debt Instrument [Line Items]
Interest Rate	2.50%
Total debt	$ 40,507	4,476
W.E.T. Term Note
Debt Instrument [Line Items]
Interest Rate	2.00%
Total debt	$ 12,897	18,852
German Investment Corporation
Debt Instrument [Line Items]
Interest Rate	4.25%
Total debt	$ 5,403
Capital Lease Obligations
Debt Instrument [Line Items]
Interest Rate	4.20%
Total debt	$ 2,814	1,140
Bank of China
Debt Instrument [Line Items]
Total debt		$ 3,172

Information Related to Recurring Fair Value Measurement of Derivative Instruments (Detail) $ in Thousands	Sep. 30, 2013 USD ($)
Derivative Asset Fair Value Net
Asset Derivatives, Fair Value, Total	$ 2,695
Fair Value, Inputs, Level 2 \| Foreign Currency Derivatives
Derivative Liability Fair Value Net
Net Asset/(Liabilities)	2,638
Fair Value, Inputs, Level 2 \| Foreign Currency Derivatives \| Noncurrent Assets
Derivative Asset Fair Value Net
Asset Derivatives, Fair Value, Total	2,403
Fair Value, Inputs, Level 2 \| Currency Related Swap \| Noncurrent Liabilities
Derivative Liability Fair Value Net
Net Asset/(Liabilities)	(12,029)
Fair Value, Inputs, Level 2 \| Not a hedge \| Foreign Currency Derivatives
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(57)
Fair Value, Inputs, Level 2 \| Not a hedge \| Foreign Currency Derivatives \| Current Assets
Derivative Liability Fair Value Net
Net Asset/(Liabilities)	289
Fair Value, Inputs, Level 2 \| Not a hedge \| Foreign Currency Derivatives \| Noncurrent Assets
Derivative Liability Fair Value Net
Net Asset/(Liabilities)	2,403
Fair Value, Inputs, Level 2 \| Not a hedge \| Foreign Currency Derivatives \| Current Liabilities
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(57)
Net Asset/(Liabilities)	(54)
Fair Value, Inputs, Level 2 \| Not a hedge \| Currency Related Swap
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(12,029)
Fair Value, Inputs, Level 2 \| Not a hedge \| Currency Related Swap \| Current Liabilities
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(2,476)
Fair Value, Inputs, Level 2 \| Not a hedge \| Currency Related Swap \| Noncurrent Liabilities
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(9,553)
Fair Value, Inputs, Level 2 \| Designated as Hedging Instrument \| Interest Rate Swap \| Current Liabilities
Derivative Liability Fair Value Net
Liability Derivatives, Fair value	(119)
Net Asset/(Liabilities)	(119)
Fair Value, Inputs, Level 2 \| Contract One \| Not a hedge \| Foreign Currency Derivatives \| Current Assets
Derivative Asset Fair Value Net
Asset Derivatives, Fair Value, Total	3
Fair Value, Inputs, Level 2 \| Contract Two \| Not a hedge \| Foreign Currency Derivatives \| Current Assets
Derivative Asset Fair Value Net
Asset Derivatives, Fair Value, Total	$ 289

Information Relate to Effect of Derivative Instruments on Our Consolidated Income Statements (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	$ 155	$ (985)	$ (1,538)	$ (792)
Revaluation Of Derivatives \| Foreign Currency Derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	581	(2,036)	(694)	(2,514)
Revaluation Of Derivatives \| Currency Related Swap
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	(364)	1,045	1,895	1,315
Revaluation Of Derivatives \| Commodity derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives		(2)		143
Foreign Currency Gain (Loss) \| Foreign Currency Derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	(426)	1,051	(844)	1,722
Interest Expense \| Interest Rate Swap
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	8	(12)	8	(54)
Other Comprehensive Income (Loss)
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	$ 30	$ (25)	$ 105	$ (55)

Derivative Financial Instruments - Additional Information (Detail) € in Thousands, $ in Thousands	1 Months Ended		9 Months Ended
	Mar. 31, 2013 EUR (€)	Mar. 31, 2008	Sep. 30, 2013 USD ($)	Sep. 30, 2013 EUR (€)	Sep. 30, 2013 EUR (€)
W.E.T.
Derivative Instruments [Line Items]
Derivative variable rate basis			six month EURIBOR	six month EURIBOR
Fixed interest rate			0.45%		0.45%
Basis spread on variable rate			1.40%		1.40%
Exchange rate			1.23		1.23
Derivative exchange rate			1.46		1.46
W.E.T. \| Interest Rate Swap
Derivative Instruments [Line Items]
Derivative maturity period		10 years
Derivative notional amount			$ 13,508		€ 10,000
Unicredit Bank
Derivative Instruments [Line Items]
Legal settlement for CRS	€ 144
Costs of all future obligations under CRS			12,030	€ 8,906
Past due payments under CRS			$ 6,659	€ 4,930